Skinvisible, Inc.
SKVI
$0.35
-$0.18-33.78%
OTC PK
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| SG&A Expenses | 10.15% | 15.87% | 24.36% | 19.81% | 11.48% |
| Depreciation & Amortization | 0.50% | 12.30% | 10.70% | 10.22% | 8.06% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 9.77% | 15.74% | 23.87% | 19.46% | 11.37% |
| Operating Income | -10.14% | -16.35% | -24.86% | -20.25% | -11.86% |
| Income Before Tax | 58.55% | 55.51% | 51.96% | 76.26% | 52.24% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 58.55% | 55.51% | 51.96% | 76.26% | 52.24% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 58.55% | 55.51% | 51.96% | 76.26% | 52.24% |
| EBIT | -10.14% | -16.35% | -24.86% | -20.25% | -11.86% |
| EBITDA | -10.55% | -16.51% | -25.40% | -20.65% | -11.99% |
| EPS Basic | 60.89% | 54.48% | 47.14% | 72.10% | 52.23% |
| Normalized Basic EPS | 20.66% | 14.22% | 5.83% | 52.01% | 52.21% |
| EPS Diluted | 60.39% | 53.98% | 46.63% | 71.85% | 52.39% |
| Normalized Diluted EPS | 20.66% | 14.22% | 5.83% | 52.01% | 52.21% |
| Average Basic Shares Outstanding | 25.54% | 20.78% | 16.02% | 11.49% | 0.00% |
| Average Diluted Shares Outstanding | 25.54% | 20.78% | 16.02% | 11.49% | 0.00% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |